Product Images Levetiracetam

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 10 images provide visual information about the product associated with Levetiracetam NDC 0409-1886 by Hospira, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - levetiracetam 01

Chemical Structure - levetiracetam 01

Figure 1 - levetiracetam 02

Figure 1 - levetiracetam 02

The given text seems to be presenting some figures and doses of Levetiracetam medication ranging from 1000 mg/day to 3000 mg/day for a total of 101 individuals. It does not provide any other useful information for further description.*

Figure 2 - levetiracetam 03

Figure 2 - levetiracetam 03

Figure 3 - levetiracetam 04

Figure 3 - levetiracetam 04

Figure 4 - levetiracetam 05

Figure 4 - levetiracetam 05

The text represents the results of a study, with two different groups (placebo and levetiracetam) with 97 and 101 individuals respectively. The numbers 44.6% and 19.6% are possibly percentages of effectiveness or side effects of the drugs, although it is not clear without the context of the study.*

Figure 5 - levetiracetam 06

Figure 5 - levetiracetam 06

This appears to be a chart or table with percentages listed for four different categories. The categories and their respective percentages are not clear, nor is the context in which they are being presented. Additionally, there is mention of a "placebo" and a drug called "Levetiracetam" with a sample size of 58, indicating that this may pertain to a medical or pharmaceutical study. Without further information or context, it is difficult to provide a more specific or accurate description.*

Figure 6 - levetiracetam 07

Figure 6 - levetiracetam 07

This document appears to display some numbers and one word - "Placebo". It is not clear what the context of these numbers or this word is, as there is no additional text or surrounding information to provide any further details. Therefore, a useful description cannot be generated from this text.*

Logo - levetiracetam 08

Logo - levetiracetam 08

PRINCIPAL DISPLAY PANEL - 5 mL Vial Label - levetiracetam 09

PRINCIPAL DISPLAY PANEL - 5 mL Vial Label - levetiracetam 09

This is a single-dose vial of Levetiracetam Injection, USP. The vial contains 5 mL of medication. The NDC number is 0409-1886-15. The instruction insert should be referred to for dosage information. This medication is for intravenous use and should be diluted prior to administration. It is manufactured in Hyderabad, India. The storage temperature should be between 20-25°C (68-77°F). The lot number and expiration date are not available.*

PRINCIPAL DISPLAY PANEL - 5 mL Vial Carton - levetiracetam 10

PRINCIPAL DISPLAY PANEL - 5 mL Vial Carton - levetiracetam 10

Levetiracetam injection is a medication that comes in single-dose vials (25x5mL NDCOK09-1286:05 and 25x5mL NDC 0409-1886-05). Each vial contains 500 mg of Levetiracetam, which must be diluted before intravenous use, and then discarded if any portion is remaining after administration. The recommended dosage and instructions for use are provided by PREMIERProRx. *

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.